Connor, Clark & Lunn Investment Management (CC&L)’s Altimmune ALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-40,705
| Closed | -$250K | – | 1398 |
|
|
2024
Q3 | $250K | Buy |
40,705
+22,188
| +120% | +$136K | ﹤0.01% | 1288 |
|
|
2024
Q2 | $123K | Buy |
+18,517
| New | +$123K | ﹤0.01% | 1301 |
|
|
2023
Q4 | – | Sell |
-34,052
| Closed | -$88.5K | – | 1366 |
|
|
2023
Q3 | $88.5K | Sell |
34,052
-132,309
| -80% | -$344K | ﹤0.01% | 1301 |
|
|
2023
Q2 | $587K | Buy |
166,361
+87,804
| +112% | +$310K | ﹤0.01% | 945 |
|
|
2023
Q1 | $332K | Buy |
+78,557
| New | +$332K | ﹤0.01% | 989 |
|
|
2022
Q4 | – | Sell |
-127,562
| Closed | -$1.63M | – | 1191 |
|
|
2022
Q3 | $1.63M | Buy |
+127,562
| New | +$1.63M | 0.01% | 537 |
|
|
2021
Q4 | – | Sell |
-40,435
| Closed | -$457K | – | 1072 |
|
|
2021
Q3 | $457K | Buy |
+40,435
| New | +$457K | ﹤0.01% | 788 |
|
|
2017
Q2 | – | Sell |
-294
| Closed | -$72K | – | 809 |
|
|
2017
Q1 | $72K | Buy |
+294
| New | +$72K | ﹤0.01% | 864 |
|